Soumit Roy
Stock Analyst at Jones Trading
(1.51)
# 3,297
Out of 4,876 analysts
42
Total ratings
18.75%
Success rate
-6.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARA Protara Therapeutics | Initiates: Buy | $21 | $2.98 | +604.70% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $22.81 | +75.36% | 1 | May 20, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $36 → $27 | $21.52 | +25.46% | 2 | May 16, 2025 | |
| ACRV Acrivon Therapeutics | Downgrades: Hold | n/a | $1.31 | - | 2 | May 16, 2025 | |
| ONCY Oncolytics Biotech | Downgrades: Hold | n/a | $0.72 | - | 2 | May 16, 2025 | |
| MURA Mural Oncology | Downgrades: Hold | n/a | $2.47 | - | 2 | Mar 25, 2025 | |
| CRVO CervoMed | Upgrades: Buy | $15 | $7.11 | +111.12% | 3 | Mar 13, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $1.97 | +407.61% | 1 | Mar 12, 2025 | |
| BEAM Beam Therapeutics | Upgrades: Buy | $34 | $17.14 | +98.37% | 2 | Mar 10, 2025 | |
| INAB IN8bio | Upgrades: Buy | $36 | $2.16 | +1,566.67% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $2.52 | +1,169.84% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.74 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $7.89 | +14.07% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $10.50 | +61.90% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.12 | +513.21% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $0.67 | +496.48% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.83 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.76 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $7.75 | +235.48% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $23.52 | +197.62% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $35.01 | -71.44% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.00 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $8.00 | +900.00% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.65 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $4.22 | +7,482.94% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $4.14 | +19,465.22% | 1 | Feb 24, 2021 |
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $2.98
Upside: +604.70%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $22.81
Upside: +75.36%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $21.52
Upside: +25.46%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.31
Upside: -
Oncolytics Biotech
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.72
Upside: -
Mural Oncology
Mar 25, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.47
Upside: -
CervoMed
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $7.11
Upside: +111.12%
Nuvation Bio
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $1.97
Upside: +407.61%
Beam Therapeutics
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $17.14
Upside: +98.37%
IN8bio
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $2.16
Upside: +1,566.67%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $2.52
Upside: +1,169.84%
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.74
Upside: -
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $7.89
Upside: +14.07%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $10.50
Upside: +61.90%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $2.12
Upside: +513.21%
Sep 11, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.67
Upside: +496.48%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.83
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.76
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $7.75
Upside: +235.48%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $23.52
Upside: +197.62%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $35.01
Upside: -71.44%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.00
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $8.00
Upside: +900.00%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.65
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $4.22
Upside: +7,482.94%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $4.14
Upside: +19,465.22%